Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Item 9 Labs Corp (INLB)
OTHER OTC:INLB
Item 9 Labs (INLB) Stock Price & Analysis
28 Followers
INLB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.10
Previous Close$0.01
Volume97.43K
Average Volume (3M)N/A
Market Cap
$10.24K
Enterprise Value$34.12M
Total Cash (Recent Filing)$183.43K
Total Debt (Recent Filing)$34.30M
Price to Earnings (P/E)>-0.1
Beta0.13
Next Earnings
Aug 15, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding102,362,271
10 Day Avg. Volume20,663,255
30 Day Avg. VolumeN/A
Standard Deviation0.29
R-Squared0.02
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.73
Enterprise Value/Gross Profit4.67
Enterprise Value/Ebitda-7.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
20.50%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
79.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INLB FAQ
What was Item 9 Labs Corp’s price range in the past 12 months?
Item 9 Labs Corp lowest stock price was <$0.01 and its highest was $0.10 in the past 12 months.
What is Item 9 Labs Corp’s market cap?
Currently, no data Available
When is Item 9 Labs Corp’s upcoming earnings report date?
Item 9 Labs Corp’s upcoming earnings report date is Aug 15, 2023 which is 249 days ago.
How were Item 9 Labs Corp’s earnings last quarter?
Item 9 Labs Corp released its earnings results on May 17, 2023. The company reported -$0.034 earnings per share for the quarter, beating the consensus estimate of -$0.04 by $0.006.
Is Item 9 Labs Corp overvalued?
According to Wall Street analysts Item 9 Labs Corp’s price is currently Overvalued.
Does Item 9 Labs Corp pay dividends?
Item 9 Labs Corp does not currently pay dividends.
What is Item 9 Labs Corp’s EPS estimate?
Item 9 Labs Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Item 9 Labs Corp have?
Item 9 Labs Corp has 102,362,274 shares outstanding.
What happened to Item 9 Labs Corp’s price movement after its last earnings report?
Item 9 Labs Corp reported an EPS of -$0.034 in its last earnings report, beating expectations of -$0.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Item 9 Labs Corp?
Currently, no hedge funds are holding shares in INLB
---
Company Description
Item 9 Labs Corp
Item 9 Labs Corp. engages in the development, manufacture, and distribution of nasal breathing devices. Its products includes filtered, and non-filtered nasal dilator-breathing devices. The filtered product also contains 3M filtration media for allergy sufferers. The company was founded by Bryce Skalla on June 15, 2010 and is headquartered in Scottsdale, AZ.
---
INLB Stock 12 Months Forecast
Average Price Target
―---